User:Alteripse/AAT

Review of current therapies.

Genetics.

Prospects for gene therapy.

Molecular pathophysiology.

Possible advantages of AAT.

Epidemiology.

Abnormal AAT accumulation attracts neutrophils.

Clinical manifestations and natural history. xxx

Liver aspects of AAT.

AAT in 26 year olds.

New treatments.

Risk modification.

CT scanning for monitoring.

Gene therapy for AAT; recent attempts.

Perspectives on treatments as of 2000.

New perspective on pathophysiology: damage results from overload as well as deficiency.

Monitoring with CT.

Brief review and intro to thorax review series.

Current iv therapies for AAT.

Lancet review already cited. xxx

Mortality is earlier mainly due to lung and liver disease.

Delayed diagnosis.

Alpha-1 foundation.

More than a PI imbalance?

AAT in 86 yr old, cirrhosis, no emphysema, normal life expectancy.